The UK Medicines and Healthcare Products Agency has revised its guidance for notified bodies wanting to consult the agency with regard to medical devices incorporating ancillary medicinal substances. The latest document replaces an earlier version of the guidance from 2003. An MHRA ...
Please Login to read the full article.
